Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK – Insiders said late last week that Pfizer will name CME-KHBB/Minneapolis the agency for its new $10-million Reactine antihistamine business. Also, the company may give Tatham Euro RSCG an undisclosed product as a result of the pitch for the Reactine account. Neither agency would comment. Both agencies were finalists for the Reactine business.
Copyright Adweek L.P. (1993)
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in